Share ownership Guardant Health, Inc.

GH

US40131M1099

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 12/05/2026 BST			5-day change	1st Jan Change
99.94 ^USD	+3.34%		+11.64%	-2.15%

05-12	Guardant Health, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10:40 AM
05-08	Guardant Health, Inc., Q1 2026 Earnings Call, May 07, 2026

Share class: Guardant Health, Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	132,599,929	127,066,783 ( 95.83 %)	0	95.83 %

Major shareholders: Guardant Health, Inc.

Name	Equities	%	Valuation
BlackRock Advisors LLC 7.807 %	10,240,933	7.807 %	892 M $
Vanguard Capital Management LLC 5.024 %	6,589,394	5.024 %	574 M $
Vanguard Portfolio Management LLC 4.451 %	5,837,992	4.451 %	508 M $
T. Rowe Price International Ltd. 4.297 %	5,636,078	4.297 %	491 M $
Vanguard Capital Management LLC 4.288 %	5,624,180	4.288 %	490 M $
Invesco Advisers, Inc. 4.053 %	5,315,934	4.053 %	463 M $
Baillie Gifford & Co. 2.942 %	3,859,046	2.942 %	336 M $
Capital Research & Management Co. (International Investors) 2.69 %	3,528,656	2.69 %	307 M $
Fiduciary Trust Company International 2.563 %	3,361,547	2.563 %	293 M $
Geode Capital Management LLC 2.45 %	3,213,657	2.45 %	280 M $
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	90.38%
Other	10.01%
Individuals	3.87%
State Street Corp.	2.13%
Manulife Financial Corp.	0.48%
Sumitomo Mitsui Trust Group, Inc.	0.37%
SEI Investments Co.	0.25%
Schweizerische Nationalbank	0.17%
Rathbones Group Plc	0.16%
Polar Capital Holdings Plc	0.12%
Fifth Third Bancorp	0.05%
Baader Bank AG	0.01%
Governments	0.01%
Banque Cantonale Vaudoise	0.01%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	85.58%
United Kingdom	12.3%
Individuals	3.87%
Canada	1.42%
Norway	0.98%
Singapore	0.8%
Austria	0.63%
Japan	0.48%
Germany	0.44%
Czech Republic	0.35%
Switzerland	0.29%
Sweden	0.17%
France	0.17%
Australia	0.12%
Luxembourg	0.12%
Ireland	0.07%
Netherlands	0.06%
Denmark	0.05%
Finland	0.03%
Cayman Islands	0.02%
China	0.02%
Poland	0.01%
Italy	0.01%
Belgium	0.01%
South Korea	0.01%
Taiwan	0.01%

Based on 1000 largest holdings

Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx test, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. It offers other tests, including Guardant360 Tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.

Employees

2,498

Sector

Medical Equipment, Supplies & Distribution

More about the company